CD155 promotes the progression of colorectal cancer by restraining CD8+ T cells via the PI3K/AKT/NF-κB pathway

Abstract Background CD155 is a crucial factor in the regulation of T cell function and contributes to immune escape. CD155 upregulation has been found in several types of cancer. However, the mechanism by which CD155 regulates CD8+ T cell function in colorectal cancer remains unclear. Here we invest...

Full description

Saved in:
Bibliographic Details
Main Authors: Rongpu Liang, Liting Liu, Dongbing Ding, Yiquan Li, Jiannan Ren, Bo Wei
Format: Article
Language:English
Published: Springer 2025-02-01
Series:Cancer Immunology, Immunotherapy
Subjects:
Online Access:https://doi.org/10.1007/s00262-025-03947-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571693645692928
author Rongpu Liang
Liting Liu
Dongbing Ding
Yiquan Li
Jiannan Ren
Bo Wei
author_facet Rongpu Liang
Liting Liu
Dongbing Ding
Yiquan Li
Jiannan Ren
Bo Wei
author_sort Rongpu Liang
collection DOAJ
description Abstract Background CD155 is a crucial factor in the regulation of T cell function and contributes to immune escape. CD155 upregulation has been found in several types of cancer. However, the mechanism by which CD155 regulates CD8+ T cell function in colorectal cancer remains unclear. Here we investigated the role and mechanism of CD155 in the regulation of CD8+ T cell function. Methods We studied the expression of CD155 in colorectal cancer tissues through western blot, immunohistochemistry, and the TCGA database. We verified the effects of CD155 on the functions of colorectal cancer cells and CD8+ T cells through in vitro experiments. We demonstrated that CD155 affects CD8+ T cell migration and thus promotes tumor growth in a mouse subcutaneous tumor model. We then tested the changes in the PI3K/AKT/NF-κB pathway in CD8+ T cells by flow cytometry. Results We demonstrated that stable CD155 expression was negatively correlated with prognosis in colorectal cancer patients. In vitro experiments confirmed that CD155 does not affect tumor cell proliferation, migration, or invasion. We also revealed that CD155 downregulated the function and migration of CD8+ T cells in vivo and in vitro. Furthermore, CD155 might regulate CD8+ T cells function via the PI3K/AKT/NF-κB pathway. Conclusion This study revealed that CD155 can promote the progression of colorectal cancer by regulating the PI3K / AKT-NF-κB pathway to promote the depletion of CD8+ T cells and reduce their migration to the tumor microenvironment. CD155 may become an important prognostic biomarker and an effective target for colorectal cancer immunotherapy.
format Article
id doaj-art-f72ae193a6be443294c8245a45380b4d
institution Kabale University
issn 1432-0851
language English
publishDate 2025-02-01
publisher Springer
record_format Article
series Cancer Immunology, Immunotherapy
spelling doaj-art-f72ae193a6be443294c8245a45380b4d2025-02-02T12:26:23ZengSpringerCancer Immunology, Immunotherapy1432-08512025-02-0174311410.1007/s00262-025-03947-yCD155 promotes the progression of colorectal cancer by restraining CD8+ T cells via the PI3K/AKT/NF-κB pathwayRongpu Liang0Liting Liu1Dongbing Ding2Yiquan Li3Jiannan Ren4Bo Wei5Department of Gastrointestinal Surgery, The Third Affiliated Hospital of Sun Yat-Sen UniversityDepartment of Pediatrics, The Third Affiliated Hospital of Sun Yat-Sen UniversityDepartment of Gastrointestinal Surgery, The Third Affiliated Hospital of Sun Yat-Sen UniversityDepartment of Gastrointestinal Surgery, The Third Affiliated Hospital of Sun Yat-Sen UniversityDepartment of Gastrointestinal Surgery, The Third Affiliated Hospital of Sun Yat-Sen UniversityDepartment of Gastrointestinal Surgery, The Third Affiliated Hospital of Sun Yat-Sen UniversityAbstract Background CD155 is a crucial factor in the regulation of T cell function and contributes to immune escape. CD155 upregulation has been found in several types of cancer. However, the mechanism by which CD155 regulates CD8+ T cell function in colorectal cancer remains unclear. Here we investigated the role and mechanism of CD155 in the regulation of CD8+ T cell function. Methods We studied the expression of CD155 in colorectal cancer tissues through western blot, immunohistochemistry, and the TCGA database. We verified the effects of CD155 on the functions of colorectal cancer cells and CD8+ T cells through in vitro experiments. We demonstrated that CD155 affects CD8+ T cell migration and thus promotes tumor growth in a mouse subcutaneous tumor model. We then tested the changes in the PI3K/AKT/NF-κB pathway in CD8+ T cells by flow cytometry. Results We demonstrated that stable CD155 expression was negatively correlated with prognosis in colorectal cancer patients. In vitro experiments confirmed that CD155 does not affect tumor cell proliferation, migration, or invasion. We also revealed that CD155 downregulated the function and migration of CD8+ T cells in vivo and in vitro. Furthermore, CD155 might regulate CD8+ T cells function via the PI3K/AKT/NF-κB pathway. Conclusion This study revealed that CD155 can promote the progression of colorectal cancer by regulating the PI3K / AKT-NF-κB pathway to promote the depletion of CD8+ T cells and reduce their migration to the tumor microenvironment. CD155 may become an important prognostic biomarker and an effective target for colorectal cancer immunotherapy.https://doi.org/10.1007/s00262-025-03947-yCD155Colorectal cancerCD8
spellingShingle Rongpu Liang
Liting Liu
Dongbing Ding
Yiquan Li
Jiannan Ren
Bo Wei
CD155 promotes the progression of colorectal cancer by restraining CD8+ T cells via the PI3K/AKT/NF-κB pathway
Cancer Immunology, Immunotherapy
CD155
Colorectal cancer
CD8
title CD155 promotes the progression of colorectal cancer by restraining CD8+ T cells via the PI3K/AKT/NF-κB pathway
title_full CD155 promotes the progression of colorectal cancer by restraining CD8+ T cells via the PI3K/AKT/NF-κB pathway
title_fullStr CD155 promotes the progression of colorectal cancer by restraining CD8+ T cells via the PI3K/AKT/NF-κB pathway
title_full_unstemmed CD155 promotes the progression of colorectal cancer by restraining CD8+ T cells via the PI3K/AKT/NF-κB pathway
title_short CD155 promotes the progression of colorectal cancer by restraining CD8+ T cells via the PI3K/AKT/NF-κB pathway
title_sort cd155 promotes the progression of colorectal cancer by restraining cd8 t cells via the pi3k akt nf κb pathway
topic CD155
Colorectal cancer
CD8
url https://doi.org/10.1007/s00262-025-03947-y
work_keys_str_mv AT rongpuliang cd155promotestheprogressionofcolorectalcancerbyrestrainingcd8tcellsviathepi3kaktnfkbpathway
AT litingliu cd155promotestheprogressionofcolorectalcancerbyrestrainingcd8tcellsviathepi3kaktnfkbpathway
AT dongbingding cd155promotestheprogressionofcolorectalcancerbyrestrainingcd8tcellsviathepi3kaktnfkbpathway
AT yiquanli cd155promotestheprogressionofcolorectalcancerbyrestrainingcd8tcellsviathepi3kaktnfkbpathway
AT jiannanren cd155promotestheprogressionofcolorectalcancerbyrestrainingcd8tcellsviathepi3kaktnfkbpathway
AT bowei cd155promotestheprogressionofcolorectalcancerbyrestrainingcd8tcellsviathepi3kaktnfkbpathway